New Chair and Deputy Chair elected to ECHA Management Board New Chair and Deputy Chair elected to ECHA Management Board Nina Cromnier has been re-elected as Chair while Karel Blaha becomes the new Deputy Chair ADC Therapeutics adds eight new members of staff ADC Therapeutics adds eight new members of staff As the company continues to expand its pipeline of antibody drug conjugates Nanobiotix expands operations into the US Nanobiotix expands operations into the US Senior pharmaceutical executive appointed as Vice President of Corporate Development Kevin Williams joins Lonza as Senior Scientist, Endotoxin Detection Kevin Williams joins Lonza as Senior Scientist, Endotoxin Detection He has more than 30 years of hands-on experience in pharmaceutical quality control Pistoia Alliance appoints Business Development Director North America Pistoia Alliance appoints Business Development Director North America Organisation looks to expand its global reach New recruits bring two decades of compliance and data management experience to Veeva Europe New recruits bring two decades of compliance and data management experience to Veeva Europe Guillaume Roussel and Francesca D’Angelo join the company Catalent makes two promotions Catalent makes two promotions To support drug development and clinical trial growth in the US, Europe and Asia Array BioPharma appoints Victor Sandor as Chief Medical Officer Array BioPharma appoints Victor Sandor as Chief Medical Officer Clinical oncology expert joins as the company advances its late-stage clinical programmes Dr Thomas Colacot wins 2015 ACS Industrial Chemistry Award Dr Thomas Colacot wins 2015 ACS Industrial Chemistry Award In recognition of his contribution to the area of catalysis Almac appoints two marketing directors Almac appoints two marketing directors Matt Cocking and Laura Montgomery join the Irish CDMO Jarrod Longcor joins Avillion as Chief Business Officer Jarrod Longcor joins Avillion as Chief Business Officer Will take responsibility for negotiating co-development agreements and financial investments TiGenix makes two appointments TiGenix makes two appointments A new Chief Medical Officer and VP of Medical Affairs and New Product Commercialisation join the company Drew Young joins EMD Serono as Senior Vice President, Neurology and Immunology Drew Young joins EMD Serono as Senior Vice President, Neurology and Immunology Joins the US biopharmaceutical company from Biogen Idec Alexander Karle becomes CEO of Evaluate Alexander Karle becomes CEO of Evaluate Founder Jonathan de Pass to become Chairman Vifor Pharma appoints heads of International Business Operations and Global Marketing Vifor Pharma appoints heads of International Business Operations and Global Marketing They will be based at company headquarters in Zurich, Switzerland Nabriva Therapeutics hires Colin Broom as CEO Nabriva Therapeutics hires Colin Broom as CEO Also establishes new US subsidiary in the Philadelphia area Merck makes two management changes Merck makes two management changes To take effect on 1 January 2015 Novimmune appoints Adrian Mills as Chief Business Officer Novimmune appoints Adrian Mills as Chief Business Officer Also becomes a member of the Executive Committee Exova appoints Alison Clayton as General Manager of European pharmaceutical business Exova appoints Alison Clayton as General Manager of European pharmaceutical business Her career spans more than 20 years in pharmaceuticals Clondalkin Group appoints new Managing Director in Poland Clondalkin Group appoints new Managing Director in Poland Tomasz Krogulski will lead pharma and healthcare packaging facility in Lublin Miriam Monge to join Sartorius Stedim Biotech as Director of Marketing for Integrated Solutions Miriam Monge to join Sartorius Stedim Biotech as Director of Marketing for Integrated Solutions Brings more than 20 years of experience to the role Basilea appoints Chief Commercial Officer Basilea appoints Chief Commercial Officer David Veitch joins the company on 1 September Aesica appoints new Product Release Manager Aesica appoints new Product Release Manager Adam Burgess will be based at the plant in Queenborough, Kent, UK Dr Paul Blake becomes Chief Development Officer at Oxford BioMedica Dr Paul Blake becomes Chief Development Officer at Oxford BioMedica Will take responsibility for the clinical development of pipeline of gene and cell therapies